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Glomerular epithelial cell products stimulate mesangial cell prolifera.
tion in culture. Glomerular epithelial cells (GEC) and mesangial cells
(MC) are both involved in glomerular diseases. To elucidate potential
interactions between these glomerular cell types, we examined whether
products of GEC affect the proliferative activity of MC. We found that
cultured rat GEC secrete soluble factors into the supernate (GEC-CM) that
induce proliferation of quiescent rat MC. The mitogenic activity was trypsin
sensitive and partially heat-labile. Biochemical analysis of GEC-CM by gel
filtration HPLC, reverse phase HPLC, and isoelectric focusing revealed at
least three mitogenic fractions as well as inhibitoiy activity present in
GEC-CM. Competitive binding assays with 1251-labeled PDGF did not show
significant amounts of PDGF in GEC-CM. The biochemical features of the
GEC-derived MC growth factors are distinct from IL-6, PDGF, bFGF, and
endothelin, previously described GEC-derived MC growth factors. Addition-
ally, significant contributions of known growth factors such as IL-i, IL-2, IL-3,
IL-4, IL-5, TNFu, TGFp, and GM-CSF are unlikely. The results indicate that
GEC produce several biochemically-distinct MC growth regulators. While
these epithelial cell-derived mitogens for MC require further characteriza-
tion, they may play an important role in the regulation of MC replication,
such as during embryogenesis and glomerular disease.
The glomerular mesangium containing mesangial cells (MC)
and extracellular matrix is involved in many pathological pro-
cesses of the kidney. Proliferation of normally quiescent MC is a
common occurrence in several forms of glomerulonephritis, in-
cluding IgA nephropathy, membranoproliferative glomerulone-
phritis, and lupus nephritis [1]. By the use of cell culture tech-
niques, several factors regulating MC turnover in vitro could be
identified [2], including various cytokines such as IL-i [3], PDGF
[4], basic FGF [5] and IL-6 [61. In vitro, many of the growth factors
are produced by MC and are thought to stimulate MC prolifera-
tion in an autocrine manner. There is increasing evidence [7—10]
that these factors are present in various forms of glomerulone-
phritis, regulating MC proliferation in vivo as well.
The origin of such cytokines in glomerular disease is still
unclear. They may be secreted in vivo by inflammatory cells or
platelets, which are present in many pathological processes of the
glomerulus [7]. However, in certain forms of glomerular injury no
infiltrating cells are present, and the mitogenic agents are pro-
duced locally within the glomerulus. As outlined above, MC can
produce growth factors with autocrine activity. Additionally,
resident neighboring glomerular cells are capable of producing
growth factors, thereby stimulating MC in a paracrine manner.
Glomerular visceral epithelial cells (GEC) [11, 12] and glomerular
endothelial cells [13] have been shown in cell culture experiments
to produce potential MC growth factors. Direct stimulation and
inhibition of MC growth by podocyte derived factors has been
observed [11], however, the growth factors were not further
characterized.
GEC (or podocytes) play an important role in the maintenance
of normal glomerular architecture and permselectivity [14, 15]. It
is also evident that GEC contribute to the initiation and propa-
gation of glomerular diseases, such as in membranous nephropa-
thy [16, 17]. Injury to GEC may lead to abnormal glomerular
permeability and to structural alterations of the integrity of the
glomerular basement membrane leading to proteinuria. Further
epithelial damage may finally result in glomeruloscierosis, seen in
Heymann nephritis or puromycin aminonucleoside-induced ne-
phropathy, diseases thought to have an initial podocyte damage
[14—17]. In idiopathic nephrotic syndrome seen in childhood,
diffuse mesangial proliferation is found in combination with
podocyte damage [16]. The mechanisms, however, which lead to
mesangial dysfunction after podocyte damage are presently un-
clear. It seems likely that growth factors or cytokines, such as
PDGF, are important mediators of glomerular injury [i, 2]. To
elucidate potential interactions between glomerular cells, we
investigated whether products of GEC can directly stimulate MC
proliferation in culture.
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METHODS
Animals
Male Sprague-Dawley rats, 150 to 200 g (The Charles River
Breeding Laboratories, Wilmington, MA, USA) were used to
isolate glomeruli.
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Medium and reagents
To grow MCs, we used DMEM (Gibco, Grand Island, NY,
USA) supplemented with 5 g/ml bovine insulin (Sigma, St.
Louis, MO, USA), 50 U/mi penicillin, 50 jtg/ml streptomycin and
10% heat-inactivated (56°C, 30 mm) fetal calf serum (FCS;
Gibco). The GECs were grown in KI medium containing DMEM-
Ham's F10 (1:1; Gibco) with 2.5% NuSerum (Collaborative
Research, Bedford, MA, USA), hormone supplements (insulin 5
ig/ml; PGE1 25 ng/ml; T3 0.325 ng/ml; Na2SeO3 1.73 ng/ml;
Transferrin 5 t.tg/ml; Hydrocortisone 18.12 ng/ml; Sigma) and
antibiotics (50 U/mi penicillin, 50 tg/ml streptomycin; Sigma)
added. Recombinant human PDGF and '251-PDGF (BB dimer)
were purchased from BTI (Stoughton, MA, USA); recombinant
human TGF-/31 was purchased from R&D Systems (Minneapolis,
MN, USA). All other recombinant cytokines (human IL-la and
human IL-1f3; human TNFa; human IL-6; human IL-2; murine
IL-3; murine IL-4; murine IL-5; murine GM-CSF) were pur-
chased from Genzyme Corp. (Boston, MA, USA).
Glomerular cell culture
Primary cultures of MC were obtained from outgrowths of
collagenase-treated isolated rat renal glomeruli as described [3, 6,
18]. Briefly, intact glomeruli were prepared by serial sieving of
cortex homogenates of blood-free kidneys. The glomerular prep-
arations had less than 5% tubular cell contamination. They were
incubated with bacterial collagenase (type IV; Sigma) for 30
minutes at 37°C, a process that results in shedding of glomerular
epithelial cells. Washed glomerular remnants, consisting of MC
and endothelial cells, were plated at a density of 200 to 300
remnants/cm2 in 20% FCS containing medium and incubated at
37°C in a humidified 5% CO2 atmosphere. Under these condi-
tions, a homogeneous outgrowth of elongated or stellate cells
appeared within seven days and reached confluency within two to
three weeks. These cells are considered vascular smooth muscle-
like MC using morphological and immunohistochemical criteria
[3, 6, 18]. In addition, all cells stained strongly positive with a
monoclonal Thy 1.1 antibody, a marker for rat MC in kidney
sections and in cell culture [18, 19]. Endothelial cells and resident
glomerular macrophages are not viable under the growth condi-
tions employed. At confluence, no cells stained positive for factor
VIII, Ia antigen and rat leukocyte common antigen. Fibroblast
contamination was excluded by growing the MC in D-valine
containing media. Passaged MCs were obtained by incubating a
washed confluent monolayer with a solution of trypsin (0.5 mg/ml;
Sigma) and EDTA (0.2 mg/mI) for five minutes at 37°C. At this
time, MCs were freed by gentle agitation and 10% FCS medium
was added. The subcultures of MCs revealed stable morphologic
and functional features.
GEC were established from glomerular explants as previously
described [20]. In brief, whole glomeruli from male Sprague
Dawley rats were explanted onto culture dishes (Falcon, Becton
Dickinson, Oxnard, CA, USA) that were coated with collagen
(Vitrogen Collagen, Palo Alto, CA, USA). After seven to nine
days, colonies of GEC were marked on the culture dish and were
excised with the collagen. Cells were replated onto collagen-
coated multiwell dishes, and wells growing pure colonies of GEC
were then expanded. The cells were grown on collagen matrices in
KI medium. Passaged GEC were obtained by incubating a washed
confluent monolayer with a solution of collagenase IV (0.2%;
Worthington Biochemical, Freehold, NJ, USA) for 30 minutes at
37°C. At this time, GEC were spun (200 g) for three minutes, the
supernatant discarded, and the cells incubated in 0.5 ml trypsin-
EDTA (trypsin, 0.5 mg/mi; EDTA, 0.2 mg/mI; Sigma) for five
minutes at 37°C. To break up cell clumps the suspension was
vigorously pipetted with a Pasteur pipet. To stop the reaction Ki
medium was added, the cells were spun, the supernatant dis-
carded, and the cells in Ki medium resuspended. Passaged GEC
from a continous cell line [20—22] were used for all experiments.
The epithelial nature of these cells was established by their
polygonal shape and cobblestone apperarance at confluence,
cytotoxic susceptibility to low doses of aminonucleoside of puro-
mycin, positive immunofluorescence staining for cytokeratin, and
presence of junctional complexes by electron microscopy. Addi-
tionally these cells secrete collagen and laminin in a polarized
fashion, express complement regulatory proteins, a3f31 integrins,
and antigens that are present on rat GEC and that contribute to
subepithelial immune deposits in vivo. Thus these cells have
several characteristics displayed by visceral GEC in vivo [20—22].
Preparation of conditioned medium
Subconfluent monolayer of GEC in 75 cm2 flasks were washed
twice with HBSS and 13 ml serum-free medium was added
(without FCS, NuSerum, or hormones). Control medium had
identical consistency with conditioned medium, except that it was
not incubated with glomerular epithelial cells. Control medium
was prepared by incubation of 13 ml serum-free medium on
collagen coated flasks. It was always processed in parallel, and
treated in the same way as the conditioned medium. After
incubation the medium was collected and spun at 400 )< g to
remove cellular debris. The cell free supernatant was concen-
trated 10- to 20-fold by allowing it to equilibrate in dialysis tubing
(Spectrapor No.1; molecular wt cutoff 6 to 8000; Spectrum
Medical md., Los Angeles, CA, USA) surrounded by polyethyl-
ene glycol compound (Sigma) at room temperature. The retentate
was dialyzed against low conductivity H20, filtered with a 0.22 jim
filter (Millex GS; Millipore Corp., Bedford, MA, USA), aliquoted
and stored at —20°C. To achieve further concentration for
biochemical characterization of MC-CM, the aliquots were dried
under vacuum centrifugation and resuspended in a smaller vol-
ume of low conductivity H20. For initial biochemical character-
ization GEC-CM and control medium were incubated with trypsin
(Sigma; 50 j.g/ml in RPMI) for three hours at 37°C. Subsequently
the reaction was stopped by adding soybean trypsin inhibitor
(Sigma; 1.25 mg/mI in RPMI) for one hour at 37°C. Control
medium was incubated with soybean trypsin inhibitor and RPMI
alone. In two experiments heparinase (Sigma; 7.25 U/ml) was
added for three hours atr 37°C, Additionally, GEC-CM and
control medium were incubated for 30 minutes at 60°C or boiled
for 10 minutes at 100°C.
MC proliferation assay
MC proliferation was determined by measuring the incorpora-
tion of [3H]thymidine as previously described [18]. Briefly, MC
(4th to 10th passages) were plated at a density of 2 to 3000
cells/well in 96-well flat bottom tissue culture plates (Costar). MC
were grown to subconfluency in 10% FCS containing medium and
subsequently starved for four to six days in 200 j.tl 0.5% FCS
containing medium in order to make MC quiescent. At this point,
control medium or growth factors were added and [3H]thymidine
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incorporation was determined after 24, 48 and 72 hours. For the
final 24 hours of incubation MC were pulsed with I 1iCi/well
3H-thymidine (3H-TdR; specific activity 1 Ci = 37 GBq, 6.7
mCi/mmol; NEN), diluted in PBS. The cells were washed twice
with PBS without Ca2 and Mg2, trypsinized for 15 minutes (0.5
mg/mi trypsin and 0.2 mg/mI EDTA) at 37°C and collected with an
automated cell harvester (Cambridge Technologies Inc.). 3H-TdR
incorporation was measured in a Searle liquid scintillation
counter. All values represent a mean determination (± SD) of at
least quadruplicate samples.
MC counts were done as previously described [61. In short, 4 x
IO MC in complete MC medium were added to each well of a
24-well flat bottom tissue culture plate (Costar). Adherence,
washing, period of quiescence, and experimental conditions were
identical to the steps described above. At the indicated time
points the MCs were washed twice with PBS. After incubation at
37°C with 200 .d trypsirifEDTA per well for 15 minutes the trypsin
reaction was stopped with 150 .d MC medium containing 20%
FCS. Trypan blue (50 jii, 0.4%) was added to each well before
aliquots of the single cell suspension were counted using a
hemocytometer. All values represent a mean determination (±
SD) of at least triplicate samples.
Reverse-phase high pressure liquid chromatography (HPLC)
Reverse-phase HPLC was performed with a 250 X 4.6 mm
HiPore RP318 C18 column (Bio-Rad Laboratories, Rockville
Center, NY, USA) using a Bio-Rad Gradient Processor HPLC
system as previously described [6, 181. Solvent A was 0.05%
trifluoroacetic acid in water and solvent B was 0.05% trifluoro-
acetic acid in acetonitrile. All reagents were HPLC grade. Sam-
ples (0.5 ml) were filtered with a 0.45 lLm fluoropolymer HPLC
filter (Gelman Sciences, Ann Arbor, MI, USA), and injected into
the C18 column. A linear gradient from 33 to 67% solvent B over
45 minutes was initiated at a flow rate of 1.0 mI/mm. Fractions (1.0
ml) were collected in 12 x 75 polypropylene tubes, dried under
vacuum centrifugation, and maintained at —20°C until assay when
samples were resuspended in 0.5 ml medium. Optical density was
continuously monitored at 220 nm.
Get filtration HPLC
Samples (0.5 ml) were analyzed by injection into a Bio-Sil TSK 125
(Bio-Rad Laboratories) column using a Bio-Rad Gradient Processor
HPLC system [6, 18]. The material was eluted with PBS (0.15 M
NaCI, 10 m phosphate, pH 7.4) at a flow rate of 1.0 mI/mm and 0.4
ml fractions were collected in 12 x 75 mm polypropylene tubes. The
fractions obtained following gel filtration-HPLC were tested for
functional activity. Optical density was continuously monitored at
220 nm. The column was calibrated using chromatography molecular
weight standards (Bio-Rad Laboratories).
Granulated-bed isoelectric focusing
Concentrated GEC-CM was obtained as described above,
dialyzed extensively against deionized water, and further concen-
trated with a vacuum centrifuge. Ampholytes, pH 3.5 to 10 (LKB,
Piscataway, NJ, USA) were added to 1.5 ml of dialyzed, concen-
trated GEC-CM for a final ampholyte concentration of 2%. The
material was added to a 20 X 20 cm electrofocusing tray contain-
ing 50 ml of electrofocusing gel (Bio-Rad Laboratories) with 2%
ampholytes [181. The anode solution was 1 N H3P04. The cathode
solution was I N NaOH. IEF was carried out in a Bio-Phoresis
Horizontal Electrophoresis Cell (Bio-Rad Laboratories) at a
constant power of 14 Watts for 3.5 hours at 4°C [17]. Gel fractions
were removed, 1.5 ml of H2O was added, and the pH was
measured with a combination pH electrode. Each sample was
then extensively dialyzed against deionized water, filtered with a
0.45 ,m fluoropolymer HPLC filter (Gelman Sciences), dried
under vacuum centrifugation and maintained at —20°C until assay
when samples were resuspended in 1.2 ml medium.
Competitive receptor binding assay with '251-PDGF
After washing with DMEM confluent MC in 24 well plates
(Costar) were incubated twice (1 hr at 37°C) with binding medium
(4 mg/mI BSA in DMEM) according to a previously published
method for rat MCs [23]. The cells were co-incubated for two
hours at 4°C with 25I-labeled PDGF (recombinant hPDGF,
BB-dimer; BTI Technologies; specific activity 50 .LCi/g, 10
ng/ml) and unlabeled PDGF, GEC-CM or control medium,
respectively. For negative control '251-PDGF was incubated with
binding medium alone. Nonspecific binding was determined by
adding 1 g/ml unlabeled rhPDGF and did not exceed 12%. After
washing the cell bound 1251-PDGF was determined and compete-
tive binding units were calculated (1 unit = 1% binding inhibi-
tion). All experiments were done in triplicate and the mean SD
of a representative experiment (N = 4) is shown.
RESULTS
All preparations of GEC-CM (10th to 20th GEC passages)
induced the proliferation of quiescent rat MC (3rd to 20th
passages). Control medium did not induce MC proliferation.
First, we analyzed the time course of GEC-CM on MC prolifer-
ation. GEC-CM (20%, vol/vol, 4 experiments) inceased MC
proliferation 2.4-fold (± 1.7) after 24 hours, 5.8-fold (± 1.8) after
48 hours, and 4.1-fold (± 2.5) after 72 hours, respectively.
Concentrated (x 12), dialyzed GEC-CM obtained after 48 hours
of incubation (4 different preparations) increased 3H-TdR incor-
poration by MC 2.9-fold (± 0.6) at 24 hours, 6.7-fold (± 2.5) at 48
hours, and 8.0-fold (± 3.6) at 72 hours of incubation at 1.25%
(vol/vol). A representative experiment is shown in Figure 1. In
comparison to arginine vasopressin (AVP), a potent growth factor
for quiescent MC [24], GEC-CM had a similar growth-promoting
activity at 48 hours and 72 hours. However, GEC-CM showed
only weak mitogenic acitivity during the initial 24 hours of
incubation. For most subsequent experiments, we analyzed 3H-
TdR incorporation of MC after 48 hours incubation. Cell count
experiments confirmed these data, showing a steady rise in MC
number over five days (Fig. 2). After adding 20% GEC-CM
(vol/vol), we observed a 2.9-fold increase in MC number, 10%
GEC-CM (vol/vol) led to an twofold increase (not shown).
Control medium did not induce MC proliferation. As positive
control, 5% FCS increased MC proliferation more than 14-fold
after five days.
Next, we analyzed the time course of the appearance of
mitogenic activity present in GEC-CM. As shown in Figure 3,
there was a constant rise of mitogenic activity during the first 48
hours, suggesting active secretion into the medium by GECs.
After 48 hours, we observed a decline of mitogenic activity,
possibly due to inhibitory factors present in the conditioned
medium since further dilutions of GEC-CM led to an increase in
mitogenic activity. However, after prolonged incubation (> 48 hr)
with serum-free medium, we observed many detached GEC.
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Fig. 1. Mesangial cell proliferation assay. Arginine vasopressin (10—6 M,
AVP, positive control), 0.5% BSA in DMEM (negative control);
GEC-CM (1.25%, vol/vol, 12-fold concentration, obtained after 48 hr
incubation) and control medium (1.25%, vol/vol, 13-fold concentration,
obtained after 48 hr incubation) were added to subconfluent quiescent (5
days 0.5% FCS) rat MC. MC proliferation was determined 24 hours (•),
48 hours () and 72 hours (E) after factor addition. Mean SD of a
representative experiment (N = 4) is shown.
150
0 1 2 3
Incubation time, days
Fig. 2. Mesangial cell counts. GEC-CM (0) (20%, vol/vol. obtained after
48 hr incubation) and control medium (•) (20%, vol/vol, obtained after 48
hr incubation) was added to subconfluent quiescent (5 days 0.5% FCS) rat
MC. Before and on days 1, 2, 3, and 5 after factor addition MC number
was determined in triplicates (24-well plate). Mean SD of a represen-
tative experiment (N = 3) is shown.
These cells clearly were viable (> 95% by Trypan blue exclusion)
and GEC could be used for further passaging. In most subsequent
experiments, we used GEC-CM harvested after 48 hours of
incubation. Dose response analysis of unconcentrated GEC-CM
demonstrated the same or sometimes higher mitogenic activity in
diluted medium. This effect was even more pronounced in con-
centrated GEC-CM (Fig. 4). The initial dilutions led to an
increase in MC proliferation, with subsequent dilutions showing a
dose-dependent reduction of mitogenic activity. We found no
Time of GEC incubation, hours
Fig. 3. Mesangial cell proliferation assay. GEC-CM (•) and control
medium (0) were collected at the indicated times and added (5%, vol/vol)
to subconfluent quiescent (5 days 0.5% FCS) rat MC. Proliferation
(mean SD) was determined 72 hours after factor addition.
40
Dilution
Fig. 4. Mesangial cell proliferation assay. Dose response analysis of
concentrated (12-fold) dialyzed GEC-CM (0, obtained after 48 hr incu-
bation) and concentrated (13-fold) dialyzed control medium (•, obtained
after 48 hr incubation) on MC proliferation. The indicated dilutions were
added to subconfluent, quiescent (5 days 0.5% FCS) rat MC. Proliferation
(mean SD) was determined 48 hours after factor addition.
toxic effect on MCs (> 95% viability by Trypan blue exclusion).
These results indicated the presence of stimulatory and inhibitory
components in GEC-CM.
Trypsin treatment (3 experiments) totally abolished the stimu-
latory effect of GEC-CM. Boiling (10 mm at 100°C, 4 experi-
ments) and heating (30 mm at 60°C, 4 experiments) substantially
reduced mitogenic activity by 55% and 46%, respectively. Initial
biochemical characterization suggested partially heat-labile pro-
teins responsible for mitogenic activity. After treatment with
heparinase (2 experiments) 3H-TdR uptake by MC was doubled,
suggesting inhibitory heparin-like activity present in GEC-CM.
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Fig. 5. Mesangial cell proliferation assay. Gel filtration HPLC analysis of
GEC-CM (•) and control medium (tlfl) (A) and concentrated (28-fold)
dialyzed GEC-CM (+) and concentrated (22-fold) dialyzed control
medium (E) (B). A total of 0.5 ml of GEC-CM and of control medium
(obtained after 48 hr incubation) was separated on a TSK 125 gel filtration
HPLC column. Individual fractions (50 rl, 20% vol/vol) were assayed for
their ability to affect MC proliferation (mean so) after 48 hours. The
column was calibrated using chromatography molecular weight standards
(Bio-Rad Laboratories).
Using gel filtration HPLC we further characterized the mito-
genie activity. In unconcentrated GEC-CM we found a single peak
of activity between 15 and 20 kDa, which was maximal around 17
kDa. A representative experiment is shown in Figure SA. Con-
centrated GEC-CM repeatedly showed at least three mitogenic
fractions with molecular weight species > 400 kDa, broad activity
between 10 and 40 kDa, and between 7.5 to 1.3 kDa (Fig. SB).
Inhibitory fractions were found in the range of 150 to 45 kDa.
Control medium did not alter MC proliferation.
Analysis of concentrated GEC-CM using reverse phase HPLC
(Fig. 6) revealed three distinct mitogenic fractions, whereas the
control medium was negative. One fraction did not bind to the
C18 column, another major peak of activity eluted between 42 and
44% acetonitrile and a third minor peak eluted between 49 and
51% acetonitrile.
Isoelectric focusing of GEC-CM (Fig. 7) showed at least two
distinct p1 forms of the mitogenic activity of concentrated GEC-
CM. Major activity was found at p1 of 3.2, and 4.2 to 4.9. Minor
activity was detectable between p1 of 5.1 to 5.8 and veiy weak
activity between p1 of 6.1 to 6.9. A second experiment confirmed
these data. Control medium was negative as was unconcentrated
GEC-CM.
Additionally, we looked for the presence of PDGF, a potent
mitogen for MC [12]. Using a competitive receptor binding assay
for PDGF on mesangial cells we could not detect significant
amounts of PDGF in GEC-CM (Table 1) in four experiments.
Even concentrated GEC-CM (12-fold) did not contain PDGF as
detected by this assay.
Analysis of potential effects of different recombinant cytokines
(Fig. 8) in the MC proliferation assay excluded major contribu-
tions of these peptides to the mitogenic activity present in
GEC-CM since they did not induce mesangial cell proliferation at
24 hours, 48 hours and 72 hours. Recombinant human IL-la (100
to 0.1 U/mI), human IL-1/3 (100 to 1 U/mI), human IL-2 (20 to 2
U/mi), murine IL-3 (500 to 5 U/ml), murine IL-4 (1000 to I U/mI),
niurine IL-S (500 to 5 U/mI), human TNFa (500 to I ng/ml),
murine GM-CSF (500 to 5 ng/ml), and human TGF-f31 (100 to 0.2
ng/mi) did not induce proliferation of quiescent MC. In three
experiments, high concentrations of human IL-2 (200 U/mI)
seemed to inhibit MC proliferation, whereas human IL-6 (100 to
10 U/mI) exhibited stimulatory activity (2-fold increase of 3H-TdR
incorporation), as previously demonstrated [6].
DISCUSSION
While renal injury in various forms of GN is known to involve
MC and GEC the mechanisms by which the stimuli induce these
changes are only beginning to be understood. The regulation of
MC turnover in the glomerulus may play an important role in a
number of physiologic and pathologic processes, including differ-
entiation, aging and various forms of glomerular disease. Cultured
MC and GEC are a useful tool in studying cell physiology. GEC
in culture secrete basement membrane components as well as
their degrading enzymes [14, 25]. Recent studies have shown the
production of endothelin [26], PDGF [12], and bFGF [271 by
cultured GEC, factors which are known to he potent stimuli for
MC proliferation [2]. Castellot et al [11] showed that heparin-like
proteins produced by GEC are effective inhibitors of MC prolif-
eration in vitro. In addition to this inhibitory activity, the authors
found growth promoting activity in the supernatant of GECs,
however did not further characterize this activity.
The MC growth factors are produced and released into the
supernatant under serum-free conditions, extending previous
observations by other investigators [11, 12, 27]. Proliferation of
quiescent MC was detectable after 24 hours of incubation,
however, proliferation was maximal between 48 hours and 72
hours of incubation, suggesting possible direct and/or indirect (via
the release of mitogens by stimulated MC) stimulation of MC
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Fig. 6. Mesangial cell proliferation assay.
Reverse phase HPLC analysis of GEC-CM (0)
60 and control medium (•) collected after 48
hours. Concentrated (28-fold), dialyzed GEC-
CM and concentrated (22-fold), dialyzed
40 control medium were separated on a C-18
reverse-phase column. A gradient of
acetonitrile (35 to 70%; dashed line) and H20
20 with TFA was used to elute the column.
Individual fractions (1 ml) were recovered from
the column, dried under vacuum centrifugation,
0 and resuspended in DMEM. Individual
fractions (50 l, 20% vol/vol) were assayed for
their ability to affect MC proliferation (mean
SD) after 48 hours.
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Fig. 7. Mesangial cell proliferation assay.
Isoelectric focusing analysis of GEC-CM.
Concentrated (26-fold) GEC-CM (0) was
dialyzed extensively against low conductivity
H,O and separated by horizontal isoelectrie
focusing. A pH range from 3.2 to 9.2 (dashed
line) was assayed to detect the presence of
isoelectric forms at the extremes of physiologic
pH. Individual fractions (50 l, 20%, vol/vol;
open circles) were assayed for their ability to
induce MC proliferation (mean SD). DMEM
(50 l, 20% vol/vol) was added for negative
control: 5954 316 cpm.
proliferation. In order to chacterize the mitogenic activity, we
performed biochemical characterizations, which showed the pres-
ence of several biochemically distinct mitogenic fractions in
GEC-CM.
PDGF is one of the most important MC mitogens [2, 4]. PDGF,
a basic heat-stable protein with an apparent molecular wt of 30
kDa, is released by many different cell types, including MC.
Fioege, Johnson and Alpers [12] observed weak expression of
PDGF mRNA transcripts in GEC maintained in serum containing
medium. After stimulation with IL-i, an increase of PDGF
mRNA was found in GEC. First, we looked for the presence of
PDGF protein in GEC-CM. Since medium supplemented with
serum contains small amounts of PDGF we used GEC-CM
obtained under serum-free conditions. Results of the radiorecep-
tor binding assay excluded significant amounts (> 6 ng/ml) of
PDGF in our preparations of GEC-CM. The molecular weight of
the mitogenic activity found in unconcentrated GEC-CM was
approximately 17 kDa, which further excluded PDGF (30 kDa) as
the main mitogen. Finally, we could not detect basic proteins that
had mitogenic activity. Taken together these results exclude major
contributions of PDGF to the mitogenic activity present in
GEC-CM.
Table I. Competitive receptor binding assay with '25l-PDGF
Inhibition units
(mean SD)
PDGF
60 ng/ml 35.8 4.4
24 ng!ml 20.3 3.1
12 ng/ml 5.8 1.4
6 ng/ml 0.5 2.5
Control 0.0 4.1
GEC-CM 0.1 2.3
Control medium 0.3 2.4
GEC-CM (11.5-fold cone.) 2.8 5.8
Control medium (14.9-fold cone.) 2.3 5.5
Confluent rat MC were co-incubated with unlabeled PDGF, GEC-CM,
control medium, and "I-labeled PDGF (10 ng/ml) for 2 hr at 4°C. For
negative control, '251-PDGF was incubated with binding medium alone.
After determining cell bound 125l-PDGF, competitive binding units were
calculated (1 unit = 1% inhibition). The mean SD of triplicate
determinations of a representative experiment (N = 3) is shown.
Takeuchi et al [27] observed the production of bFGF by GEC.
Basic FGF is a cationic protein (p1 9.6) with potent mitogenic
activity for cultured MC [28]. Due to the lack of typical signal
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Fig. 8. Mesangial cell proliferation assay. FCS
(10%, vol/vol), GEC-CM (5%, vol/vol; obtained
after 48 hr incubation), control medium (5%,
vol/vol; obtained after 48 hr incubation), 0.5%
BSA/RPMI and different recombinant cytokines
(human TGFP, 20 ng/ml; human TNFa, 100
ng/ml; murine GM-CSF, 500 ng/ml; human IL-
Ia, 100 U/mI; human IL-113, 100 U/mI; human
IL-2, 200 U/mI; murine IL-3, 500 U/mI; murine
IL-4, 1000 U/mI; murine IL-5, 500 U/mI; human
IL-6, 100 U/mI) dissolved in 0.5% BSA/RPMI
were added to subconfluent quiescent (5 days
0.5% FCS) rat MC. Seventy-two hours after
addition of these factors MC proliferation
(mean so) was determined.
sequences, which are characteristic for secreted proteins, bFGF is
probably released predominantly during cell injury [27, 28]. Once
released, bFGF rapidly binds to matrix components, mainly
heparan sulfate proteoglycan [27]. Recently, Francki et al [281
found small amounts of a 16 kDa isoform of bFGF in the
supernatant of stimulated MC; however, most activity was present
in cellular MC fractions. Even in the presence of serum-contain-
ing medium Takeuchi et al [27] detected only small amounts of
bFGF mRNA in GECs using RT-PCR. These observations make
the presence of significant amounts of bFGF in the supernatant of
unstimulated GEC unlikely. Moreover, our data using isoelectric
focusing of GEC-CM did not show any contribution of cationic
proteins to the mitogenic activity. Therefore, we conclude that
bFGF is not responsible for the GEC-derived mitogenic activity.
Endothelin peptides are important MC growth factors [21.
Recently, Kasinath et al [26] observed that GEC under serum free
conditions secrete endothelin-1 into the supernatant. Endothe-
lin-1 has a molecular weight of approximately 2.5 kDa, which is
much smaller than the mitogenic activity we observed in GEC-
CM. Additionally, the dialysis tubing used during the preparative
process has a molecular weight cut-off between 6 to 8 kDa, which
excludes contributions of smaller peptides, such as endothelin and
epidermal growth factor (molecular wt 6 kDa) in concentrated
GEC-CM. The presence of smaller stimulatory molecules in gel
filtration-HPLC of concentrated GEC-CM therefore suggests the
presence of degraded higher molecular weight mitogens res-
posible for mitogenic activity below 6 kDa, which was underlined
by the presence of a large smear in the protein readout despite
previous dialysis.
IL-I has been shown to be an autocrine growth factor for MC
[3], mainly in combination with other cytokines or serum compo-
nents. In our experiments IL-I did not elicit a growth response on
its own, which is in keeping with other reports [2, 28, 29] and
makes contributions of IL-I to the observed GEC-derived mito-
genie activity unlikely. Other cytokines such as IL-2, IL-3, IL-4,
IL-5, TNFa, GM-CSF [181 and TGFf3 did not induce MC
proliferation in our test system.
Confirming our previous data [61, high concentrations of IL-6
are mitogenic for cultured rat MC. Recently, Moutabarrik et al
[30] and Osawa et at [31] reported up-regulated IL-6 secretion by
GECs after cytokine stimulation. Both groups found only minor
constitutive secretion of IL-6 by GEC. In order to provoke a
relatively modest growth response of cultured MC, high concen-
trations of IL-6 are necessary. In contrast, our results demonstrate
that unconcentrated GEC-CM elicits a strong mitogenic response.
Additionally, IL-6 has a different molecular weight-profile on gel
filtration HPLC [6] and a different profile on reverse phase HPLC
[6] as compared to the mitogenic activity in GEC-CM. Thus, our
results do not provide any evidence for a significant role of IL-6 in
the growth response of cultured MCs elicited by GEC-CM. Taken
together, these results virtually exclude contributions of several
known MC growth factors to the mitogenic activity present in
GEC-CM. It is therefore likely that we have described an addi-
tional and distinct GEC-derived MC growth factor.
In addition to growth-promoting activity, GEC produce inhib-
itory molecules. This extends previous observations by Castellot et
al [11]. They attributed the inhibitory activity found in GEC-CM
to heparin-like species because heparinase treatment abolished
the antimitogenic effect on MC proliferation. Confirming their
finding, our data show that heparinase treatment leads to a
substantial increase in GEC-derived mitogenic activity. The pres-
ence of growth-inhibitory molecules was further suggested by our
dilution experiments and by gel filtration HPLC, showing inhibi-
tory fractions between 150 and 45 kDa. The fact that mitogenic
activity of GEC-CM did not further increase may suggest that the
molecule was partially degraded during the preparative step or
copurifled with an inhibitor. Because MCs were clearly viable
after incubation with GEC-CM, true growth inhibition rather than
toxic effects on MC growth can be assumed. So far, growth-
inhibitory activity for MCs has been demonstrated only for few
cytokines [2]. TGFJ3 in higher concentrations decreased serum or
cytokine-induced MC proliferation [31]. In addition, antiprolif-
erative activity has been attributed to atrial natriuretic factor,
interferon y, prostanoids and nitric oxide [2]. However, all these
antimitogenic substances have considerably lower molecular
weights excluding contributions to the inhibitory activity observed
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by us. Several reports described the inhibitory effects of heparin
and heparin-like species on MC proliferation [2, 32,33]. Whether
the large molecular weight fractions of GEC-CM contain heparin-
like species such as heparan sulfate (such as in heparan sulfate
proteoglycans) was not investigated in this study. Production of
such components by GEC with a similar molecular weight has
been shown previously [33]. Their potential contribution to the
inhibitory activity of GEC-CM requires further analysis.
The GEC-derived mitogens and growth inhibitors may play a
role under different physiological and pathophysiological condi-
tions. Glomerular cells in two-dimensional culture appear to
reflect an activated cell phenotype, as seen in glomerular disease
or in rnorphogenesis [2, 29]. One could speculate that GEC-
derived growth regulators may provide proliferative and inhibi-
tory signals for quiescent MCs in vivo. In some forms of human
glomerulonephritis (for example, childhood idiopathic nephrotic
syndrome with diffuse mesangial cell proliferation or in develop-
ment of focal glomerulosclerosis) initial podocyte injury is thought
to lead to MC proliferation [14, 17]. In such circumstances,
GEC-derived cytokines could be the first step in the progression
of glomerular disease. It is also conceivable that GEC-derived
cytokines are growth factors or chemoattractants for other cell
types that enter the urinary space of the glomerulus, such as
mononuclear cells seen in crescents and parietal epithelial cells.
Additionally, the GEC-derived factors may provide a growth
regulatory signal for tubular cells under physiological and patho-
physiological conditions. Due to the process of glomerular ultra-
filtration outward flow across the glomerular capillary wall should
oppose access and action of these cytokines to the mesangial
space. However, as pointed out by Kasinath et a! [26], it is evident
that GEC are directly adjacent to MC in the perimesangial areas,
separated only by the glomerular basement membrane of the
capillary tuft. It is conceivable that molecules can diffuse across
the glomerular basement membrane from GEC toward MC in
glomerular disease with occlusion of capillaries and glomerular
basement membrane derangement. Under such conditions GEC-
derived proteins might diffuse into the mesangium and affect MC
behavior. Additionally, such GEC-derived regulatory molecules
may be involved in nephron development [34,
In conclusion, the results of this study have characterized new
GEC-derived mitogenic activity. Significant contributions of
known MC growth factors produced by epithelial cells are un-
likely. Further identification of the major individual mitogenic
fractions is a worthwhile goal, since GEC-derived growth regula-
tors may play a role in the interactions between GECs and MCs in
glomerular diseases, and during development.
Reprint requests to Dr. Kiemens Budde, Medizinische Klinik l- Universi-
tatsklinikum Charite, Schumannstr. 20/21, 70117 Berlin, Germany.
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